Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )

7.588 +0.048 (+0.64%)
Streaming Delayed Price Updated: 11:12 AM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 935,688
Open 7.500
Bid (Size) 7.590 (8)
Ask (Size) 7.600 (11)
Prev. Close 7.540
Today's Range 7.270 - 7.680
52wk Range 4.540 - 16.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November
The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions. 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Looking Into Recursion Pharmaceuticals's Recent Short Interest
Via Benzinga

Performance

YTD
+0.50%
+0.50%
1 Month
+24.19%
+24.19%
3 Month
-9.23%
-9.23%
6 Month
-18.41%
-18.41%
1 Year
-18.67%
-18.67%

More News

Read More
November Recap: Top 9 Micro/Small Cap AI Stocks Up +53%, On Average
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Hewlett Packard Enterprise Posts Upbeat Earnings, Joins Foot Locker, NetApp And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
This Stock Could Soar by 120%, According to Wall Street
Via The Motley Fool
Recursion Pharmaceuticals: Q3 Earnings Insights
Via Benzinga
2 Risky Stocks With Massive Potential
Via The Motley Fool
Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters.
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth
Via InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off?
Via The Motley Fool
Unlocking AI investment opportunities in healthcare
Via MarketBeat
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
Is Recursion Pharmaceuticals Stock a Buy Now?
Via The Motley Fool
Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock
Via Benzinga
AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Bayer and Recursion Focus Research Collaboration on Oncology
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology
From Recursion Pharmaceuticals, Inc.
Via GlobeNewswire
Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
From Recursion Pharmaceuticals
Via GlobeNewswire
3 Stocks to Buy for Their Proximity to Nvidia
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Recursion to Participate in Upcoming Investor Conference
From Recursion Pharmaceuticals
Via GlobeNewswire
The 7 Best Cathie Wood Stocks to Buy Now: November Edition
Via InvestorPlace
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
2 Reasons to Buy Recursion Pharmaceuticals, and 1 Reason to Sell
Via The Motley Fool
3 Extra-Speculative Stocks That Could Make You Very, Very Rich
Via InvestorPlace
1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.